In patients with intractable spine and limb pain, spinal stimulation was associated with better pain reduction than medical therapy, with newer stimulation technology having better effects than conventional stimulation.
Multimodal analgesia after hip or knee arthroplasty may be associated with fewer complications and reduced opioid prescriptions and hospital length of stay, compared with unimodal analgesia.
More emphasis should be placed on self-management, physical and psychological therapies for treating low back pain, rather than pharmacological or surgical treatments.
Although peripheral neuropathy is one of the most common neurologic problems seen in the primary care setting, recognizing and evaluating peripheral neuropathy in a patient can be challenging due to its diverse presentations.
The use of non-opioid analgesic therapies is increasing among ED physicians.
Various strategies to reduce opioid overdose deaths have been implemented and it has been suggested that access to medical cannabis may lead to a reduction in opioid use for pain management.
One physician shares his thoughts on the importance of balancing autonomy, beneficence, and nonmaleficence when prescribing opioids to patients.
Special caution is warranted in the administration of pain treatment to patients with severe obesity, and additional research in this population is needed.
Age, anxiety, and socioeconomic status are better predictors than race and ethnicity for health-related quality of life outcomes in patients with chronic pain.
Although much of the response to the opioid epidemic exempts treatment for cancer-related pain, a recent Oncology Nurse Advisor online survey showed that more than 80% of respondents were concerned about how current restrictions set up to manage the opioid crisis are affecting cancer patient pain management.
From helping patients with opioid addiction to finding pain management programs, one physician shares his experience with chronic pain management in the primary care setting.
The Joint Commission has provided insight into trends in opioid prescriptions over the last 3 decades, as well as current quality and safety problems in acute pain management.
The HIV Medicine Association of the Infectious Diseases Society of America has released new guidelines for the management of chronic pain in patients living with human immunodeficiency virus.
Pain is 1 the most frequent reasons for ED visits. See what an ED physician has to say about opioid prescribing and general pain management approaches in the ED.
Virtual reality technology may relieve pain through neurophysiologic changes related to conditioning and exposure, in addition to mechanisms involving distraction.
The Intelis platform monitors patient activity 24/7, which means physicians can make treatment adjustments as needed.
There is currently little conclusive evidence to suggest a benefit of cannabis use for the management of neuropathic pain.
Long-term opioid prescription use increased threefold during a 16-year period between 1999 and 2014.
The increased use of opioid prescriptions to treat chronic pain has resulted in the rise of opioid use disorder, addiction, and abuse. We offer an overview of how and when to prescribe opioids for the management of chronic pain.
Multiple new drugs for pain management have been recently introduced or approved, and additional agents are currently under investigation.
A growing body of research is showing the importance of bolstering resilience in chronic pain management.
At PAINWeek 2017, the president of the National Association of Drug Diversion Investigators discussed ways to balance pain management needs and overdose prevention measures.
Diclofenac at 150 mg/day is the most effective NSAID for treating osteoarthritic pain and physical disability, while paracetamol had nearly no effect.
gammaCore, a hand-held device for treating episodic cluster headaches via mild electrical stimulation of the vagus nerve is now available in the United States.
In a 3-year period, 45% of patients with trigeminal neuralgia received at least 3 unique treatments.
The American Diabetes Association released an updated position statement on the prevention, detection, and management of diabetic neuropathies.
Clinical Pain Advisor offers comprehensive coverage of the American Academy of Pain Medicine's annual meeting, March 16-19, 2017, in Orlando, Florida.
Ideally, internet-based and mobile-device based platforms would work together to tailor the intervention based on patient responses.
Polymorphism at the level of drug receptors, transporters, or other proteins involved in drug metabolism or action may have an impact on the effect of a drug.
While many studies have elucidated some of the intricacies of the chronic pain experience, the definition of pain has not adapted to current knowledge.
Clinical Pain Advisor Articles
- Chronic Pain May Be a Contributing Factor to Suicide
- Striking a Balance Between Opioid Surveillance and Patient Privacy
- Demographic Characteristics of Pregnant Women With Opioid Use Disorder
- Supervised Injection Sites: Facts, Information, Pros, and Cons
- Effects of Mindfulness Therapy, Pharmacologic Prophylaxis on Catecholamine Levels in Migraine
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Reviewing the Efficacy of Intrathecal Morphine, Ziconotide for Cancer- and Noncancer Chronic Pain
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Factors Associated With Suboptimal Interscalene Brachial Plexus Block for Arthroscopy
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- Scholarship Support Limited for Veterans Enrolling in MD Programs
- Alpha and Beta Band Activity in MS-Related Chronic Pain
- New Opioid-Induced Constipation Management Guidelines Available